FDA Panel Rejects Avastin For Breast Cancer

    A Food and Drug Administration panel today voted 6-0 to halt the use of cancer drug Avastin for the treatment of breast cancer, saying studies have failed to show Avastin is effective for that purpose.  The recommendation came after two days of testimony from patients, doctors, and advocacy groups. The panel faced several tearful accounts of women, young and old, who believed Avastin saved their lives. Dozens of protesters, | Read More »